BC Week In Review | Nov 22, 2010
Clinical News

Saizen somatropin regulatory update

Merck's Merck Serono S.A. unit said its liquid formulation of Saizen somatropin was recommended for approval under EU's decentralized procedure to treat growth hormone deficiency. The company expects marketing approval in individual countries over the...
BC Week In Review | Jul 20, 2009
Company News

The Medical House plc, Merck KGaA sales and marketing update

Medical House will provide Merck KGaA 's Merck Serono S.A. unit with cool.click 2, a needle-free injector system. Merck Serono will use cool.click 2 to administer its Saizen somatropin recombinant human growth hormone (hGH) to...
BC Week In Review | Oct 15, 2007
Company News

Bioject, Merck KGaA deal

Under a three-year deal, BJCT will supply its cool.click and Serojet spring-powered needle-free device for use with MRK's Merck Serono S.A. unit's recombinant human growth hormone (hGH) drugs. Financial terms were not disclosed. Bioject Medical...
BC Week In Review | Jul 3, 2000
Clinical News

Needleless formulation of Saizen regulatory update

The FDA granted marketing approval for Saizen somatropin, SEO's pediatric growth hormone, delivered using BJCT's needleless cool.click delivery system. Bioject Medical Technologies Inc. (BJCT), Portland, Ore.   Serono International S.A. (SWX:SEO), Geneva, Switzerland   Product:...
BC Extra | Jun 26, 2000
Company News

FDA clears needle-free Saizen

Bioject (BJCT) and partner Serono (SWX:SEO) received FDA marketing clearance for Saizen somatropin, SEO's pediatric growth hormone delivered using BJCT's cool.click needleless delivery system....
Items per page:
1 - 5 of 5